GB2399886A - Identifying degenerative brain disease using EEG or EMG measurements - Google Patents

Identifying degenerative brain disease using EEG or EMG measurements Download PDF

Info

Publication number
GB2399886A
GB2399886A GB0306936A GB0306936A GB2399886A GB 2399886 A GB2399886 A GB 2399886A GB 0306936 A GB0306936 A GB 0306936A GB 0306936 A GB0306936 A GB 0306936A GB 2399886 A GB2399886 A GB 2399886A
Authority
GB
United Kingdom
Prior art keywords
test data
subject
data
infected
indication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0306936A
Other versions
GB0306936D0 (en
Inventor
Andrew Paul Bowditch
Thomas Micheal Mann
Peter Colin Pearce
Elizabeth Ann Marie Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Priority to GB0306936A priority Critical patent/GB2399886A/en
Publication of GB0306936D0 publication Critical patent/GB0306936D0/en
Publication of GB2399886A publication Critical patent/GB2399886A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006ECG or EEG signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/369Electroencephalography [EEG]
    • A61B5/372Analysis of electroencephalograms
    • A61B5/374Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7253Details of waveform analysis characterised by using transforms
    • A61B5/7257Details of waveform analysis characterised by using transforms using Fourier transforms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

Early detection of degenerative brain disorders in humans and animals (e.g. BSE, scrapie, CJD) is carried out using EEG or EMG measurements. A sensor device 1 removably attached to a test subject measures the brain or muscular electrical activity of the subject, and wirelessly transmits the measured data to a processor 2. The measured data is compared with reference data taken from diseased subjects in order to determine if the test subject is infected with a degenerative brain disease. Processing may include frequency analysis and use of Fast Fourier Transform (FFT). Alternatively the data comparison and preclinical indication of disease may be carried out by a human operator by inspection of a visual representation of the data.

Description

Diagnostic Anuaratus This invention is concerned with means for analysing
for the presence of degenerative brain diseases such as BSE and scrapie in animals and CJD in man s BSE and scrapie are fatal diseases which affect livestock and have caused extensive damage in farming and related industries. These diseases have been linked to new variant CJD in humans.
If the presence of such diseases is suspected within a herd or flock, it is of paramount importance that the suspect animal or animals are isolated from the remainder without delay. There is, therefore, a need for means of identifying early preclinical indicators of these diseases. Moreover, it would be desirable to identify the presence of disease in man at as early a stage as possible to maximise opportunities for clinical intervention.
While formal diagnosis of such diseases may require the intervention of qualified medical or veterinary personnel, the current invention provides a means of identifying early indicators which facilitate optimal intervention and which could be used by personnel who are not qualified medical or veterinary practitioners.
Given that BSE and the like may take years to manifest itself in the observable behaviour or an infected animal, and there is no accepted method of confirming infection other than by examining the brain of a slaughtered animal, it has been suggested that the only safe approach to combating the disease is widespread slaughter. Inevitably, on implementation of such a policy, there will be many animals slaughtered that are not infected.
Therefore an invention that provides an aid to estimating the likelihood that an animal is infected and hence whether it should be slaughtered represents a significant advance in the art.
A common feature of the type of disease with which this invention is concerned is that neural and muscular function is compromised.
À ÀÀ À À À À À eÀ À À À À À À À À À À À À À À À À . . À. À À .
The electroencephalogram (EEG) reflects the electrical activity of populations of neurones in the brain and itrecords positive/negative fluctuations in the microvolt range ((50-200) x 10-6 V). EEG recording is state dependent and reflects ongoing brain activity in that it changes as a result of parameters such as age, sleep stage and cerebral dysfunction. In man, EEG recordings are generally used to assess brain function in conditions such as epilepsy and to monitor sleep dysfunction in this and other conditions.
The electromyogram (EMG) reflects the electrical activity of muscles. At rest, muscles are electrically quiescent. When stimulated, electrical activity increases and subsequently declines. EMG measurements are used to assess muscle weakness or wasting. This can result from either nerve or muscle impairment In such circumstances, characteristic alterations of the electrical signals can be observed.
UK Patent Application no. 0110222.7 (Publication no. GB 2375 012) describes a biotelemetry monitoring system for use in collecting monitored data from athletes in training. The system described therein includes an individual data monitoring sensor for mounting on a subject under study. The sensor includes surface electrodes and means for onward transmition of data gathered thereby.
According to this invention, apparatus for identifying early indicators of degenerative brain disease in an animal or human subject comprises means for acquiring test data representing brain or muscle electrical activity of the subject and means for providing an indication of whether the subject is infected, depending on whether the test data are normal.
In a preferred embodiment the means for acquiring test data includes means for wireless transmission of said test data. More preferrably the means for acquiring test data is adapted for temporary fixing on the subject body.
A further preferred embodiment includes means for storing reference data representing brain or muscle electrical activity of infected animals or humans; processing means for comparing the two sets of data and means for providing an À .* À . À e À À À À À À À À À À À À À À À À À À À À À À * À indication of whether the subject is infected depending on the result of the comparison.
The processing means could include means for subjecting the test data to a fast fourier transform; means for grouping the result of said transform into frequency bands and means for calculating the relative power in each band.
In another embodiment of the invention, which offers advantages of simplicity, the apparatus further comprising means for providing a visual representation of the test data and the means for providing an indication comprises a human operator.
The reference data could comprise EEG or EMG recordings although this should not be seen as limiting.
According to a second aspect of the invention, a method of identifying early indicators of degenerative brain disease in an animal or human subject comprisies the steps of acquiring test data representing brain or muscle electrical activity of from the subject and providing an indication of whether the subject is infected depending on whether the test data are normal.
Preferrably the method further comprises the steps of storing reference data representing brain or muscle electrical activity of infected animals or humans; comparing the two sets of data and providing an indication of whether the subject is infected depending on the result of the comparison.
More preferrably the method further comprises the steps of subjecting the test data to a Fast Fourier transform; grouping the result of said transform into frequency bands and calculating the relative power in each band.
The invention will now be described with reference to Figure 1 which illustrates, in schematic form, an example of how the invention might be implemented, and figure 2 which shows the results of the analysis of the EEG of three groups of animals (error bars represent the standard error of the mean).
. ..e À - . À ate c À À - À À À À À À À . ..
Àe À À À Referring to Figure 1, reference data and test data (i.e. data obtained from an animal under investigation) may be collected using a sensor 1 such as the individual data monitoring sensor described in GB 2 375 012. . The electrodes used therewith are modified/substituted according to subject under investigation.
This device has the advantage of compactness and, after attachment to the animal e.g. by strapping, can transmit data without the need for physical connection to the processor 2.
The construction of alternative devices capable of acquiring and transmitting data is within the skills of a competent engineer.
By collecting data from animals or humans that are known to be affected by a particular disease, it is possible to derive reference data having features whose presence in test data may be taken as an indicator of the presence of that disease.
Processor 2 includes means for receiving the data from device 1 and for storing both reference data and test data.
Processor 2 also includes the computing capacity necessary to compare the reference and test data and providing an output which is dependent on the result of that comparison.
The output could be used to control, for example, an LED display which indicates the presence or absence of disease.
In an alternative embodiment, processor 2 includes means for producing a visual representation of the test data and the comparison is carried out by means of inspection by an operator. By referring to reference data, the operator is able, to recognise features in the test data which indicate the presence of disease.
Referring to figure 2, brainwave (EEG) recordings were taken from 12 cows, five of which were normal (controls), five had been infected either orally or by ICV injection with Bovine Spongiform Encephalopathy (BSE) but showing no signs c...
a À À Àe a À see À À ^ À À À À À À À À ..
eve À À (preclinical) and two had been diagnosed by veterinary surgeons as showing clinical signs of BSE. The EEG was measured from the shaven forehead of each animal using the CBS5000 biopotenial recording system (Retech Electronics) and stored on hard disc via a Micro1401 (available from Cambridge Electronic Design Ltd. (CED), Science Park, Milton Road Cambridge CB4 MULE). Data were analysed using a Spike 2 (CED) customised script. The analysis consisted of removing artefacts from the recording and then subjecting the resultant waveform to Fast Fourier Transform (FFT) analysis. This analysis outputs the relative frequency components of the waveform in terms of power (pV2). These frequency components were then grouped into bands (Delta: 0-3.9Hz, Theta: 4-.9Hz, Alpha: 8-11.9Hz, Beta 1: 12-23.9Hz and Beta 2: 24-39.9Hz) and the relative power (%) in each band calculated.
The results show an obvious change in n=2 animals displaying clinical signs and that an indication of the presence of pre-clinical BSE is also possible (data lying midway between controls and those showing clinical signs). Those animals with pre-clinical and clinical BSE showed a slowing of the background EEG represented by a rise in the %Mean Power in the 4-8 Hz frequency bin (Theta) and a reduction in the Beta 1 bin (12-24Hz).
a ac e cat À e Àa a e a ace e c À c a e a e a À c a.
À. c c e a l

Claims (11)

  1. Claims 1. Apparatus for identifying early indicators of degenerative brain
    disease in an animal or human subject, comprising: means for acquiring test data representing brain or muscle electrical activity of the subject and means for providing an indication of whether the subject is infected depending on whether the test data are normal.
  2. 2. Apparatus according to claim 1 where the means for acquiring test data includes means for wireless transmission of said test data.
  3. 3. Apparatus according to claim 1 or 2 where the means for acquiring test data is adapted for temporary fixing on the subject body.
  4. 4. Apparatus according to any preceding claim and further comprising means for storing reference data representing brain or muscle electrical activity of infected animals or humans; processing means for comparing the two sets of data and means for providing an indication of whether the subject is infected depending on the result of the comparison.
  5. 5. The apparatus of claim 4, where the processing means comprises means for subjecting the test data to a fast fourier transform; means for grouping the result of said transform into frequency bands and means for calculating the relative power in each band.
  6. 6. The apparatus of claim 1 where the means for providing an indication comprises a human operator and further comprising means for providing a visual representation of the test data.
    À . . ..e À À . À À À À À À À À À - À a À : ... : À.e:e
  7. 7. The apparatus of any preceding claim where the reference data comprises an EEG.
  8. 8. The apparatus of any preceding claim where the reference data comprises an EMG.
  9. 9. A method of identifying early indicators of degenerative brain disease in an animal or human subject comprising the steps of acquiring test data representing brain or muscle electrical activity of from the subject and providing an indication of whether the subject is infected depending on whether the test data are normal.
  10. 10. A method according to claim 9 and further comprising the steps of storing reference data representing brain or muscle electrical activity of infected animals or humans; comparing the two sets of data and providing an indication of whether the subject is infected depending on the result of the comparison.
  11. 11. The method of claim 10, further comprising the steps of: subjecting the test data to a fast fourier transform; grouping the result of said transform into frequency bands and calculating the relative power in each band.
    À À . À À e e À À e À À À eee e e e e e e e À À À e.
    À. À . . .
GB0306936A 2003-03-26 2003-03-26 Identifying degenerative brain disease using EEG or EMG measurements Withdrawn GB2399886A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0306936A GB2399886A (en) 2003-03-26 2003-03-26 Identifying degenerative brain disease using EEG or EMG measurements

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0306936A GB2399886A (en) 2003-03-26 2003-03-26 Identifying degenerative brain disease using EEG or EMG measurements

Publications (2)

Publication Number Publication Date
GB0306936D0 GB0306936D0 (en) 2003-04-30
GB2399886A true GB2399886A (en) 2004-09-29

Family

ID=9955552

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0306936A Withdrawn GB2399886A (en) 2003-03-26 2003-03-26 Identifying degenerative brain disease using EEG or EMG measurements

Country Status (1)

Country Link
GB (1) GB2399886A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4583190A (en) * 1982-04-21 1986-04-15 Neuroscience, Inc. Microcomputer based system for performing fast Fourier transforms
EP0284685A2 (en) * 1987-03-30 1988-10-05 Wide Trade Foundation Ltd. Apparatus and method for detecting and processing bioelectric signals
US4978903A (en) * 1988-07-19 1990-12-18 A-Teollisuus Oy Apparatus for the control of a three-phase a.c. motor, especially a squirrel-cage motor
US5010891A (en) * 1987-10-09 1991-04-30 Biometrak Corporation Cerebral biopotential analysis system and method
WO1997038627A1 (en) * 1996-04-17 1997-10-23 British Technology Group Ltd Analysis for the presence of degenerative brain disease
US6067986A (en) * 1993-10-29 2000-05-30 Kluger; Alan Method and apparatus employing motor measures for early diagnosis and staging of dementia
WO2001060253A1 (en) * 2000-02-19 2001-08-23 Diagnostic Potentials Limited Method for investigating neurological function

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4583190A (en) * 1982-04-21 1986-04-15 Neuroscience, Inc. Microcomputer based system for performing fast Fourier transforms
EP0284685A2 (en) * 1987-03-30 1988-10-05 Wide Trade Foundation Ltd. Apparatus and method for detecting and processing bioelectric signals
US5010891A (en) * 1987-10-09 1991-04-30 Biometrak Corporation Cerebral biopotential analysis system and method
US4978903A (en) * 1988-07-19 1990-12-18 A-Teollisuus Oy Apparatus for the control of a three-phase a.c. motor, especially a squirrel-cage motor
US6067986A (en) * 1993-10-29 2000-05-30 Kluger; Alan Method and apparatus employing motor measures for early diagnosis and staging of dementia
WO1997038627A1 (en) * 1996-04-17 1997-10-23 British Technology Group Ltd Analysis for the presence of degenerative brain disease
EP0897283A1 (en) * 1996-04-17 1999-02-24 The Victoria University Of Manchester Analysis for the presence of degenerative brain disease
WO2001060253A1 (en) * 2000-02-19 2001-08-23 Diagnostic Potentials Limited Method for investigating neurological function

Also Published As

Publication number Publication date
GB0306936D0 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
US10219719B2 (en) Head-mounted electrode array
US11337633B1 (en) Method and system for electrode impedance measurement
EP0013183B1 (en) Electroencephalographic system for the quantitative description of patient brain states
Flink et al. Guidelines for the use of EEG methodology in the diagnosis of epilepsy: International league against epilepsy: Commission report commission on European Affairs: Subcommission on European Guidelines
US7016722B2 (en) System and method for fetal brain monitoring
EP2575608B1 (en) Detector for identifying physiological artifacts from physiological signals and method
US9402558B2 (en) System and method for pain detection and computation of a pain quantification index
RU2428110C2 (en) System and method for diagnostics of brain stem malfunction
EP3223693A2 (en) Non-invasive systems and methods to detect cortical spreading depression for the detection and assessment of brain injury and concussion
Chatrian et al. IFCN recommended standards for electrophysiologic monitoring in comatose and other unresponsive states. Report of an IFCN committee
JP2006502809A (en) Apparatus and method for detecting abnormalities and inconsistencies in the body
US20140058219A1 (en) Device for recording ultrasound-induced fetal eeg, and method of use
US20130096440A1 (en) Portable fetal eeg-recording device and method of use
Munro et al. Normative auditory brainstem response data for bone conduction in the dog
Tao et al. Coherence Characteristics of Gamma-band EEG during rest and cognitive task in MCI and AD
GB2399886A (en) Identifying degenerative brain disease using EEG or EMG measurements
US12089942B1 (en) Robust real-time EEG suppression detection device and method
Hazenfratz Feasibility of dry surface electrodes for electroencephalography (EEG) in dogs
RU2180753C1 (en) Method for quick diagnosis of epilepsy of children and juveniles
Henderson et al. Electroencephalogrambased methods for routine detection of dementia
RU2575052C2 (en) Diagnostic system and technique for brain stem disorders
Quang Electrophysiological methods to assess emotional stress of human body
KR20130139386A (en) Monitoring system for abnormal body reactions, and method thereof
RamaRaju et al. Incursion Model for Nomenclature of EEG Signals via Wavelet Transform

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)